127 related articles for article (PubMed ID: 8042860)
21. Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus.
Okuda T; Kurokawa M; Matsuo K; Honda M; Niimura M; Shiraki K
J Med Virol; 2004 Jan; 72(1):112-20. PubMed ID: 14635018
[TBL] [Abstract][Full Text] [Related]
22. Phenoxazine derivatives suppress the infections caused by herpes simplex virus type-1 and herpes simplex virus type-2 intravaginally inoculated into mice.
Hayashi K; Hayashi T; Miyazawa K; Tomoda A
J Pharmacol Sci; 2010; 114(1):85-91. PubMed ID: 20736512
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of herpesvirus replication by a series of 4-oxo-dihydroquinolines with viral polymerase activity.
Hartline CB; Harden EA; Williams-Aziz SL; Kushner NL; Brideau RJ; Kern ER
Antiviral Res; 2005 Feb; 65(2):97-105. PubMed ID: 15708636
[TBL] [Abstract][Full Text] [Related]
24. Harmine blocks herpes simplex virus infection through downregulating cellular NF-κB and MAPK pathways induced by oxidative stress.
Chen D; Su A; Fu Y; Wang X; Lv X; Xu W; Xu S; Wang H; Wu Z
Antiviral Res; 2015 Nov; 123():27-38. PubMed ID: 26348003
[TBL] [Abstract][Full Text] [Related]
25. 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication.
Field AK; Davies ME; DeWitt C; Perry HC; Liou R; Germershausen J; Karkas JD; Ashton WT; Johnston DB; Tolman RL
Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4139-43. PubMed ID: 6306664
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of human herpesviruses by combination of acyclovir and human leukocyte interferon.
Levin MJ; Leary PL
Infect Immun; 1981 Jun; 32(3):995-9. PubMed ID: 6166569
[TBL] [Abstract][Full Text] [Related]
27. In vitro and in vivo evaluation of a novel antiherpetic flavonoid, 4'-phenylflavone, and its synergistic actions with acyclovir.
Hayashi K; Iinuma M; Sasaki K; Hayashi T
Arch Virol; 2012 Aug; 157(8):1489-98. PubMed ID: 22580497
[TBL] [Abstract][Full Text] [Related]
28. Antiviral chemotherapy and chemoprophylaxis.
Dolin R
Science; 1985 Mar; 227(4692):1296-303. PubMed ID: 2983421
[TBL] [Abstract][Full Text] [Related]
29. Spectrum of sensitivity of acyclovir of herpes simplex virus clinical isolates.
McLaren C; Sibrack CD; Barry DW
Am J Med; 1982 Jul; 73(1A):376-9. PubMed ID: 6285726
[TBL] [Abstract][Full Text] [Related]
30. Antiviral chemotherapy.
Eggers HJ
Infection; 1984; 12(5):313-4. PubMed ID: 6210252
[No Abstract] [Full Text] [Related]
31. In vitro inhibition of herpes simplex virus type 1 replication by Mentha suaveolens essential oil and its main component piperitenone oxide.
Civitelli L; Panella S; Marcocci ME; De Petris A; Garzoli S; Pepi F; Vavala E; Ragno R; Nencioni L; Palamara AT; Angiolella L
Phytomedicine; 2014 May; 21(6):857-65. PubMed ID: 24629600
[TBL] [Abstract][Full Text] [Related]
32. Immunogenicity, protective efficacy, and non-replicative status of the HSV-2 vaccine candidate HSV529 in mice and guinea pigs.
Bernard MC; Barban V; Pradezynski F; de Montfort A; Ryall R; Caillet C; Londono-Hayes P
PLoS One; 2015; 10(4):e0121518. PubMed ID: 25837802
[TBL] [Abstract][Full Text] [Related]
33. Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with trifluorothymidine, phosphonoformate and acycloguanosine against herpes simplex viruses.
Ayisi NK; Gupta SV; Babiuk LA
Antiviral Res; 1985 Feb; 5(1):13-27. PubMed ID: 2984988
[TBL] [Abstract][Full Text] [Related]
34. Use of immunostimulatory sequence-containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection.
Pyles RB; Higgins D; Chalk C; Zalar A; Eiden J; Brown C; Van Nest G; Stanberry LR
J Virol; 2002 Nov; 76(22):11387-96. PubMed ID: 12388699
[TBL] [Abstract][Full Text] [Related]
35. Acyclovir. Pharmacology and clinical experience.
Laskin OL
Arch Intern Med; 1984 Jun; 144(6):1241-6. PubMed ID: 6329117
[TBL] [Abstract][Full Text] [Related]
36. Herpesvirus infections (cytomegalovirus, herpes simplex virus, varicella-zoster virus). How to use ganciclovir (DHPG) and acyclovir.
Drew WL; Buhles W; Erlich KS
Infect Dis Clin North Am; 1988 Jun; 2(2):495-509. PubMed ID: 2849621
[TBL] [Abstract][Full Text] [Related]
37. Broad-spectrum non-nucleoside inhibitors of human herpesviruses.
McClain L; Zhi Y; Cheng H; Ghosh A; Piazza P; Yee MB; Kumar S; Milosevic J; Bloom DC; Arav-Boger R; Kinchington PR; Yolken R; Nimgaonkar V; D'Aiuto L
Antiviral Res; 2015 Sep; 121():16-23. PubMed ID: 26079681
[TBL] [Abstract][Full Text] [Related]
38. The application of a plasmid DNA encoding IFN-alpha 1 postinfection enhances cumulative survival of herpes simplex virus type 2 vaginally infected mice.
Härle P; Noisakran S; Carr DJ
J Immunol; 2001 Feb; 166(3):1803-12. PubMed ID: 11160227
[TBL] [Abstract][Full Text] [Related]
39. Acyclovir in the treatment of infection due to herpes viruses.
Zicha J; Stafová J; Vacek V
Czech Med; 1986; 9(4):203-5. PubMed ID: 3028734
[TBL] [Abstract][Full Text] [Related]
40. Antiviral Effects of ABMA against Herpes Simplex Virus Type 2 In Vitro and In Vivo.
Dai W; Wu Y; Bi J; Wang S; Li F; Kong W; Barbier J; Cintrat JC; Gao F; Gillet D; Su W; Jiang C
Viruses; 2018 Mar; 10(3):. PubMed ID: 29522484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
